148 related articles for article (PubMed ID: 37857912)
1. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.
Akçay A; Peker AA; Oran Z; Toprak H; Toluk Ö; Balsak S; Badur BA; Gültekin MA
Abdom Radiol (NY); 2024 Jan; 49(1):229-236. PubMed ID: 37857912
[TBL] [Abstract][Full Text] [Related]
2. MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor.
Kawaguchi M; Kato H; Hatano Y; Tomita H; Hara A; Suzui N; Miyazaki T; Furui T; Morishige KI; Matsuo M
Jpn J Radiol; 2020 Aug; 38(8):782-789. PubMed ID: 32246351
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
[TBL] [Abstract][Full Text] [Related]
4. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation.
Nakai G; Yamada T; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y
J Ovarian Res; 2018 Jan; 11(1):7. PubMed ID: 29321056
[TBL] [Abstract][Full Text] [Related]
5. Role of MRI in characterizing serous borderline ovarian tumor and its subtypes: Correlation of MRI features with clinicopathological characteristics.
Li K; Song F; Yu L; Shi H; Wang J; Cheng X
Eur J Radiol; 2022 Feb; 147():110112. PubMed ID: 34972058
[TBL] [Abstract][Full Text] [Related]
6. Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
Bazot M; Haouy D; Daraï E; Cortez A; Dechoux-Vodovar S; Thomassin-Naggara I
Clin Radiol; 2013 Jan; 68(1):e1-8. PubMed ID: 23044365
[TBL] [Abstract][Full Text] [Related]
7. Perfusion-based functional magnetic resonance imaging for differentiating serous borderline ovarian tumors from early serous ovarian cancers in a rat model.
Cai SQ; Li Y; Li YA; Wang L; Zhu J; Zhao SH; Qiang JW
Acta Radiol; 2021 Jan; 62(1):129-138. PubMed ID: 32276553
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging findings of cystic ovarian tumors: major differential diagnoses in five types frequently encountered in daily clinical practice.
Ohya A; Fujinaga Y
Jpn J Radiol; 2022 Dec; 40(12):1213-1234. PubMed ID: 35916971
[TBL] [Abstract][Full Text] [Related]
9. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
Li YA; Qiang JW; Ma FH; Li HM; Zhao SH
Eur J Radiol; 2018 Jan; 98():136-142. PubMed ID: 29279152
[TBL] [Abstract][Full Text] [Related]
10. A modified diffusion-weighted magnetic resonance imaging-based model from the radiologist's perspective: improved performance in determining the surgical resectability of advanced high-grade serous ovarian cancer.
Lu J; Guo Q; Zhang Y; Zhao S; Li R; Fu Y; Feng Z; Wu Y; Li R; Li X; Qiang J; Wu X; Gu Y; Li H
Am J Obstet Gynecol; 2024 Jul; 231(1):117.e1-117.e17. PubMed ID: 38432417
[TBL] [Abstract][Full Text] [Related]
11. MRI appearances of ovarian serous borderline tumor: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Boyko OB; Wang SJ; Cai SQ; Wang L
J Magn Reson Imaging; 2014 Jul; 40(1):151-6. PubMed ID: 24923479
[TBL] [Abstract][Full Text] [Related]
12. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging].
Abdel Wahab C; Rousset P; Bolze PA; Thomassin-Naggara I
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):260-276. PubMed ID: 32004779
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy.
Nishio N; Kido A; Kataoka M; Kuwahara R; Nakao K; Kurata Y; Matsumura N; Mandai M; Togashi K
Eur J Radiol; 2018 Aug; 105():175-181. PubMed ID: 30017276
[TBL] [Abstract][Full Text] [Related]
14. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
[TBL] [Abstract][Full Text] [Related]
15. Application of apparent diffusion coefficient and exponent apparent diffusion coefficient values in magnetic resonance imaging diffusion-weighted imaging to differentiate benign and malignant ovarian epithelial tumors.
Wang YX; Yuan MZ; Wen ZX
J Cancer Res Ther; 2016; 12(1):401-5. PubMed ID: 27072270
[TBL] [Abstract][Full Text] [Related]
16. The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor.
Katsakhyan L; Baraban EG; Dumoff KL; Burger RA; Parikh R; Cooper K
Int J Gynecol Pathol; 2021 Mar; 40(2):175-179. PubMed ID: 32168063
[TBL] [Abstract][Full Text] [Related]
17. Extrauterine Pelvic Serous Carcinomas: Current Update on Pathology and Cross-sectional Imaging Findings.
Katabathina VS; Amanullah FS; Menias CO; Chen MM; Valente PT; Chintapalli KN; Prasad SR
Radiographics; 2016; 36(3):918-32. PubMed ID: 27163599
[TBL] [Abstract][Full Text] [Related]
18. MRI characteristics for differentiating mucinous borderline ovarian tumours from mucinous ovarian cancers.
Yang XY; Li X; Ma FH; Li HM; Zhao SH; Li YA; Qiang JW
Clin Radiol; 2022 Feb; 77(2):142-147. PubMed ID: 34848025
[TBL] [Abstract][Full Text] [Related]
19. MRI appearances of pure epithelial papillary serous borderline ovarian tumours.
Naqvi J; Nagaraju E; Ahmad S
Clin Radiol; 2015 Apr; 70(4):424-32. PubMed ID: 25515794
[TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient (ADC) values of serous, endometrioid, and clear cell carcinoma of the ovary: pathological correlation.
Ono T; Kishimoto K; Tajima S; Maeda I; Takagi M; Suzuki N; Mimura H
Acta Radiol; 2020 Jul; 61(7):992-1000. PubMed ID: 31698924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]